4
Changes in Ownership
PTC THERAPEUTICS, INC. Filed Acc 0001808968-26-000007
CHIEF EXECUTIVE OFFICER sold 2,514 shares at $76.45 ($192,195)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Klein Matthew B. · CHIEF EXECUTIVE OFFICER
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-01-08 | Sale : show line 1 in the form 10b5-1 | −2,514 | $76.45 | $192,195 | 394,453 | D |
| Open-market sales · 2,514 sh · avg $76.45 · $192,195 | ||||||
Loading xslF345X05/form4-01122026_050107.xml…